Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | PPARG | P37231 | 2/20 | 0.45 |
| ▸ | ALB | P02768 | 1/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.45 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.45 |
| ▸ | PGR | P06401 | 2/20 | 0.45 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | APEX1 | P27695 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8983035 | 1.00 | NR1I2 (0.45) | NR1I2MAPTPPARGALBSLC22A6 | |
| SCHEMBL8983019 | 1.00 | NR1I2 (0.45) | NR1I2MAPTPPARGALBSLC22A6 | |
| SCHEMBL9848034 | 1.00 | NR1I2 (0.45) | NR1I2MAPTPPARGALBSLC22A6 | |
| SCHEMBL18467220 | 0.95 | NR1I2 (0.45) | NR1I2MAPTPPARGALBSLC22A6 | |
| SCHEMBL9742948 | 0.95 | NR1I2 (0.44) | NR1I2MAPTPPARGALBSLC22A6 | |
| SCHEMBL18419623 | 0.95 | NR1I2 (0.45) | NR1I2MAPTPPARGALBSLC22A6 | |
| SCHEMBL18419624 | 0.95 | NR1I2 (0.45) | NR1I2MAPTPPARGALBSLC22A6 | |
| SCHEMBL8983048 | 0.94 | NR1I2 (0.51) | NR1I2MAPTPPARGALBSLC22A6 | |
| SCHEMBL8983045 | 0.94 | NR1I2 (0.51) | NR1I2MAPTPPARGALBSLC22A6 | |
| SCHEMBL12969278 | 0.93 | NR1I2 (0.45) | NR1I2MAPTPPARGALBSLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021147986-A1 | CEPHALOSPORIN ANTIBACTERIAL COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF | 上海森辉医药有限公司 | 2021-07-29 | — | — | WO | disclosed |
| US-20200316083-A1 | ANTIBACTERIAL COMPOSITIONS | WOCKHARDT LIMITED (IN) | 2020-10-08 | — | — | US | disclosed |
| WO-2017216765-A1 | ANTIBACTERIAL COMPOSITIONS | WOCKHARDT LIMITED (IN) | 2017-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200316083-A1 | ANTIBACTERIAL COMPOSITIONS | CEL, ALPI, GUSB | NR1I2 1764/4885MAPT 2183/4885PPARG 2574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.